These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 11506326)
1. The prognostic importance of c-myc oncogene expression in head and neck melanoma. Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO Ann Plast Surg; 2001 Aug; 47(2):172-7. PubMed ID: 11506326 [TBL] [Abstract][Full Text] [Related]
2. Use of oncogene expression as an independent prognostic marker for primary melanoma. Grover R; Pacifico MD; Wilson GD; Sanders R Ann Plast Surg; 2003 Feb; 50(2):183-7. PubMed ID: 12567057 [TBL] [Abstract][Full Text] [Related]
3. The clinical significance of c-myc oncogene expression in melanomas of the scalp. Chana JS; Grover R; Wilson GD; Hudson DA; Forders M; Sanders R; Grobbelaar AO Br J Plast Surg; 1998 Apr; 51(3):191-4. PubMed ID: 9664877 [TBL] [Abstract][Full Text] [Related]
4. The prognostic significance of c-myc oncogene expression in uveal melanoma. Chana JS; Cree IA; Foss AJ; Hungerford JL; Wilson GD Melanoma Res; 1998 Apr; 8(2):139-44. PubMed ID: 9610866 [TBL] [Abstract][Full Text] [Related]
5. Measurement of c-myc oncogene expression provides an accurate prognostic marker for acral lentiginous melanoma. Grover R; Chana J; Grobbelaar AO; Hudson DA; Forder M; Wilson GD; Sanders R Br J Plast Surg; 1999 Mar; 52(2):122-6. PubMed ID: 10434891 [TBL] [Abstract][Full Text] [Related]
6. A prospective analysis of c-myc oncoprotein levels as a prognostic marker in malignant melanoma. Ramsden AJ; Grover R; Chana J; Tulley P; Sanders R; Wilson GD J Plast Reconstr Aesthet Surg; 2007; 60(6):626-30. PubMed ID: 17485049 [TBL] [Abstract][Full Text] [Related]
7. Sentinel lymph node biopsy is accurate and prognostic in head and neck melanoma. Erman AB; Collar RM; Griffith KA; Lowe L; Sabel MS; Bichakjian CK; Wong SL; McLean SA; Rees RS; Johnson TM; Bradford CR Cancer; 2012 Feb; 118(4):1040-7. PubMed ID: 21773971 [TBL] [Abstract][Full Text] [Related]
8. Measurement of c-myc oncoprotein provides an independent prognostic marker for regional metastatic melanoma. Grover R; Ross DA; Wilson GD; Sanders R Br J Plast Surg; 1997 Oct; 50(7):478-82. PubMed ID: 9422944 [TBL] [Abstract][Full Text] [Related]
9. [Clinical course of cutaneous melanoma of the head and neck, and the factors affecting patient survival]. Tarkov SA; Mikhnin AE; Shelekhova KV; Frolova OS; Nefedov AO Vopr Onkol; 2013; 59(1):114-7. PubMed ID: 23814837 [TBL] [Abstract][Full Text] [Related]
10. Is sex an independent prognostic factor in cutaneous head and neck melanoma? Arce PM; Camilon PR; Stokes WA; Nguyen SA; Lentsch EJ Laryngoscope; 2014 Jun; 124(6):1363-7. PubMed ID: 24122966 [TBL] [Abstract][Full Text] [Related]
11. The c-myc oncogene: use of a biological prognostic marker as a potential target for gene therapy in melanoma. Chana JS; Grover R; Tulley P; Lohrer H; Sanders R; Grobbelaar AO; Wilson GD Br J Plast Surg; 2002 Dec; 55(8):623-7. PubMed ID: 12550114 [TBL] [Abstract][Full Text] [Related]
12. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma. Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058 [TBL] [Abstract][Full Text] [Related]
13. Extra c-myc oncogene copies in high risk cutaneous malignant melanoma and melanoma metastases. Kraehn GM; Utikal J; Udart M; Greulich KM; Bezold G; Kaskel P; Leiter U; Peter RU Br J Cancer; 2001 Jan; 84(1):72-9. PubMed ID: 11139316 [TBL] [Abstract][Full Text] [Related]
14. Prognostic implications of p53 overexpression in cutaneous melanoma from sun-exposed and nonexposed sites. Essner R; Kuo CT; Wang H; Wen DR; Turner RR; Nguyen T; Hoon DS Cancer; 1998 Jan; 82(2):309-16. PubMed ID: 9445187 [TBL] [Abstract][Full Text] [Related]
15. Prognostic importance of mitochondrial markers in mucosal and cutaneous head and neck melanomas. Soares CD; Morais TML; Carlos R; de Almeida OP; Mariano FV; Altemani A; de Carvalho MGF; Corrêa MB; Dos Reis RRD; Amorim LS; Jorge J Hum Pathol; 2019 Mar; 85():279-289. PubMed ID: 30468799 [TBL] [Abstract][Full Text] [Related]
16. Gene expression profiling of primary cutaneous melanoma and clinical outcome. Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A; J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783 [TBL] [Abstract][Full Text] [Related]
17. Antigen Ki-67 and c-myc oncogene as related to histoclinical parameters in pigmented skin lesions. Korabiowska M; Brinck U; Mirecka J; Kellner S; Marx D; Schauer A In Vivo; 1995; 9(5):433-8. PubMed ID: 8900920 [TBL] [Abstract][Full Text] [Related]
18. Expression of c-myc oncoprotein represents a new prognostic marker in cutaneous melanoma. Ross DA; Wilson GD Br J Surg; 1998 Jan; 85(1):46-51. PubMed ID: 9462382 [TBL] [Abstract][Full Text] [Related]
19. Accuracy and prognostic value of sentinel lymph node biopsy in head and neck melanomas. Patuzzo R; Maurichi A; Camerini T; Gallino G; Ruggeri R; Baffa G; Mattavelli I; Tinti MC; Crippa F; Moglia D; Tolomio E; Maccauro M; Santinami M J Surg Res; 2014 Apr; 187(2):518-24. PubMed ID: 24252855 [TBL] [Abstract][Full Text] [Related]
20. Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study. Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly J J Am Acad Dermatol; 2017 Mar; 76(3):494-498.e2. PubMed ID: 28413056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]